FindTrial
Sign In

Clinical Research of External Use of Coptidis Rhizoma Qu Taidu on Prevention of Infant Eczema

Clinical Research of External Use of Coptidis Rhizoma Qu Taidu on Prevention of Infant Eczema

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-PPC-16008666
Enrollment
Unknown
Registered
2016-06-23
Start date
2014-08-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infant eczema

Interventions

Treatment group:External washing and Nursing instruction
Contol group:Nursing instruction

Sponsors

Xiyuan Hospital China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1) Healthy full-term newborns, including eutocia and cesarean, weighting between 2500g and 4000g; 2) Newborns less than one day; 3) Newborns have score of 10 rated by Apgar method which widely accepted internationally and domestically; 4) Informed consent has been signed by custodian.

Exclusion criteria

Exclusion criteria: Newborns suffering from any diseases(including congenital diseases and skin diseases) and skin damage will not be included.

Design outcomes

Primary

MeasureTime frame
The occurrence of eczema;—

Countries

China

Contacts

Public ContactLang Na

Xiyuan Hospital China Academy of Chinese Medical Sciences

langna96@126.com+86 10 62835035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026